{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:21:49Z","timestamp":1790256109849,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151269","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T13:41:39Z","timestamp":1457617299000},"page":"e0151269","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Human FGF-21 Is a Substrate of Fibroblast Activation Protein"],"prefix":"10.1371","volume":"11","author":[{"given":"Andrew L.","family":"Coppage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn R.","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"DiMare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack H.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Bachovchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"A Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbadis.2011.04.002","article-title":"Hormone-like fibroblast growth factors and metabolic regulation","volume":"1812","author":"YC Long","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/bies.20261","article-title":"An evolutionary history of the FGF superfamily","volume":"27","author":"C Popovici","year":"2005","journal-title":"Bioessays"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"MK Badman","year":"2009","journal-title":"Endocrinology"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1210\/en.2009-0119","article-title":"Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver","volume":"150","author":"Y Hotta","year":"2009","journal-title":"Endocrinology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models\u2014association with liver and adipose tissue effects","volume":"297","author":"J Xu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1210\/en.2012-2276","article-title":"Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db\/db mice","volume":"154","author":"HW Kim","year":"2013","journal-title":"Endocrinology"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1210\/en.2012-1211","article-title":"Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys","volume":"153","author":"MM Veniant","year":"2012","journal-title":"Endocrinology"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"A Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"FM Fisher","year":"2010","journal-title":"Diabetes"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"G Gaich","year":"2013","journal-title":"Cell Metab"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"e38438","DOI":"10.1371\/journal.pone.0038438","article-title":"Fundamentals of FGF19 &amp; FGF21 action in vitro and in vivo","volume":"7","author":"AC Adams","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"X Zhang","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"T Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"R Goetz","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"40","key":"ref16","doi-asserted-by":"crossref","first-page":"34533","DOI":"10.1074\/jbc.M111.248591","article-title":"Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor\/Ets-like protein-1 in adipocytes","volume":"286","author":"X Ge","year":"2011","journal-title":"J Biol Chem"},{"issue":"9","key":"ref17","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db05-1435","article-title":"Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways","volume":"55","author":"W Wente","year":"2006","journal-title":"Diabetes"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e00065","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor-21, extends lifespan in mice","volume":"1","author":"Y Zhang","year":"2012","journal-title":"Elife"},{"issue":"1\u20132","key":"ref19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mce.2011.05.003","article-title":"The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes","volume":"342","author":"Y Zhang","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"J Xu","year":"2009","journal-title":"Diabetes"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"e49345","DOI":"10.1371\/journal.pone.0049345","article-title":"Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes","volume":"7","author":"R Hecht","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.21675","article-title":"Different roles of N- and C- termini in the functional activity of FGF21","volume":"219","author":"R Micanovic","year":"2009","journal-title":"J Cell Physiol"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jb\/mvr017","article-title":"Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate","volume":"149","author":"CH Huang","year":"2011","journal-title":"J Biochem"},{"issue":"16","key":"ref24","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.febslet.2012.06.015","article-title":"Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein alpha","volume":"586","author":"K Jambunathan","year":"2012","journal-title":"FEBS Lett"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1074\/jbc.M511112200","article-title":"Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity","volume":"281","author":"CY Edosada","year":"2006","journal-title":"J Biol Chem"},{"key":"ref26","article-title":", Novel Metabolic Disease Therapy","author":"M Gorrell","year":"2012","journal-title":"United States"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1021\/jm400351a","article-title":"Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase","volume":"56","author":"SE Poplawski","year":"2013","journal-title":"J Med Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fob.2013.12.001","article-title":"Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs","volume":"4","author":"FM Keane","year":"2013","journal-title":"FEBS Open Bio"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/dc08-1054","article-title":"Serum levels of the adipokine FGF21 depend on renal function","volume":"32","author":"S Stein","year":"2009","journal-title":"Diabetes Care"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"e58575","DOI":"10.1371\/journal.pone.0058575","article-title":"Rational design of a fibroblast growth factor 21-based clinical candidate, LY2405319","volume":"8","author":"A Kharitonenkov","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.febslet.2008.11.023","article-title":"FGF21 N- and C-termini play different roles in receptor interaction and activation","volume":"583","author":"J Yie","year":"2009","journal-title":"FEBS Lett"},{"key":"ref32","article-title":"Circulating FGF21 Proteolytic Processing Mediated by Fibroblast Activation Protein","author":"EY Zhen","year":"2015","journal-title":"Biochem J"},{"key":"ref33","article-title":"Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21","author":"DR Dunshee","year":"2016","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:08:52Z","timestamp":1540339732000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151269"}},"subtitle":[],"editor":[{"given":"Mari\u00e0","family":"Alemany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,10]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151269","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,10]]}}}